The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...

Data in this new study shows that the 2024-2025 COVID-19 vaccines provide similar protection to the previous formulation. They were found to be most protective four weeks after vaccination, providing ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, according to a study published in Nature. Using population-wide data from ...

New data released Thursday by the Centers for Disease Control and Prevention suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus. A study ...

Adults who aren’t current on their COVID-19 vaccine booster doses may have "relatively little remaining protection" against hospitalization compared to those who haven’t been vaccinated at all, ...

Covid vaccines continue to protect against serious illness and death, especially for people ages 65 and older, although the benefits for younger adults are not as clear, according to a large new study ...

A major new study examining the 2023-2024 COVID-19 vaccines shows moderate protection that works best in the first few months but weakens considerably over time. The research, published in JAMA ...

Getting a COVID vaccine or booster while pregnant can benefit both the mother and the baby, according to a new study published in the journal Vaccine. Researchers from the Infectious Diseases Clinical ...

COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...

We regularly answer frequently asked questions about life in the era of COVID-19. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject ...